Target Volume Determination 2016

Previous Page

Next Page

Page Background

Selective nodal irradiation in NSCLC:

FDG-PET based!

I

44 patients NSCLC

I

61 2-64 8 Gy (1 8 Gy BID)

I

88 patients NSCLC

I

dose-escalation study

.

. .

I

median FU: 16 months

I

median FU: 16 months

I

Isolated nodal recurrence:

1 patient (2.3%)

I

Isolated nodal recurrence:

2 patients (2.3%)

Selective nodal irradiation based on

PET

is safe in NSCLC

www.uniklinikum-dresden.de

27

De Ruysscher

et al

., IJROBP 2005

Belderbos

et al

., IJROBP 2006